In addition, high-throughput analysis of miRNAs expression in breast cancers brings about the prognostic value of breast cancer status irrespective of the influence of oestrogen on their expression and whether these miRNAs target ERα or not. This evidence concerns the gene ESR1 and breast carcinoma.